Loading clinical trials...

COMPLETEDNCT01121237

MONITOR-CKD5 - Multi-level Evaluation of Anaemia Treatment, Outcomes, and Determinants in Chronic Kidney Disease Stage 5

MONITOR-CKD5 is an observational, pharmaco-epidemiological study to evaluate the multi-level factors and outcomes associated with the treatment of renal anaemia with biosimilar epoetin alfa in Stage 5...

Lead sponsor: Sandoz•95 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITING

Assessment of T-cell Response and In-vitro Proof-of-concept of T-cell Engineering in Chronic ESKD Patients.

NCT06474169 · Chronic Kidney Diseases

RECRUITINGNA

Efficacy of pHA130 Hemoadsorption on Protein-Bound Uremic Toxins and Quality of Life in Kidney Failure

NCT07656168 · ESRD (End-Stage Renal Disease), Maintenance Hemodialysis

RECRUITINGPhase 2

Equol and Vascular Function in Women With Chronic Kidney Disease

NCT07194590 · Chronic Kidney Disease (Stage 3-4), Vascular Function, and more

RECRUITINGPhase 1

A Clinical Trial of MK-2828 in People With Kidney Disease (MK-2828-006)

NCT07348237 · Chronic Kidney Failure, End-Stage Renal Disease, and more

RECRUITING

Renal Dysfunction in Patients With Inflammatory Bowel Disease and the General Population (NEPHRO-IBD)

NCT07593352 · IBD and Renal Involement, Chronic Kidney Disease, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 6, 2016Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment2,086

Start dateFeb 2010

Last updatedApr 6, 2016

Condition

Chronic Kidney Disease End-stage Renal Disease Anaemia

Locations shown

Sandoz Investigational Site

Bregenz

Sandoz Investigational Site

Eisenstadt

Sandoz Investigational Site

Feldkirch

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 6, 2016Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

MONITOR-CKD5 - Multi-level Evaluation of Anaemia Treatment, Outcomes, and Determinants in Chronic Kidney Disease Stage 5

What this study is about

Save this trial guide to your notes

Sponsors

Related studies

Assessment of T-cell Response and In-vitro Proof-of-concept of T-cell Engineering in Chronic ESKD Patients.

Efficacy of pHA130 Hemoadsorption on Protein-Bound Uremic Toxins and Quality of Life in Kidney Failure

Equol and Vascular Function in Women With Chronic Kidney Disease

A Clinical Trial of MK-2828 in People With Kidney Disease (MK-2828-006)

Renal Dysfunction in Patients With Inflammatory Bowel Disease and the General Population (NEPHRO-IBD)

Trial snapshot

Condition

Locations shown

For caregivers